GlaxoSmithKline Pharmaceuticals Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019 - 2015
Period Ending	Sep '24 Sep 30, 2024	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	2019 - 2015
Cash & Equivalents	11,100	641.71	349.41	2,862	4,052	1,048	Upgrade
Short-Term Investments	10,008	9,794	11,009	21,791	7,320	9,570	Upgrade
Trading Asset Securities	-	8,132	5,183	3,656	-	-	Upgrade
Cash & Short-Term Investments	21,108	18,568	16,541	28,309	11,372	10,618	Upgrade
Cash Growth	31.49%	12.25%	-41.57%	148.94%	7.10%	-7.49%	Upgrade
Accounts Receivable	2,684	2,221	1,924	2,052	2,156	998.01	Upgrade
Other Receivables	-	1,275	1,373	715.31	254	306.15	Upgrade
Receivables	2,684	3,496	3,297	2,768	2,410	1,304	Upgrade
Inventory	5,176	5,250	4,600	5,347	5,467	4,830	Upgrade
Prepaid Expenses	-	206.18	149.6	139.26	146.49	117.89	Upgrade
Other Current Assets	1,175	463.33	355.04	517.62	2,631	878.19	Upgrade
Total Current Assets	30,144	27,984	24,943	37,080	22,026	17,749	Upgrade
Property, Plant & Equipment	2,976	3,107	3,151	3,254	3,554	8,271	Upgrade
Long-Term Investments	-	0.27	0.27	0.15	0.15	-	Upgrade
Other Intangible Assets	183.4	235.54	340.91	344.97	433.64	496.25	Upgrade
Long-Term Deferred Tax Assets	1,503	1,463	1,335	1,131	1,031	1,105	Upgrade
Other Long-Term Assets	2,654	2,776	2,795	2,621	4,101	3,712	Upgrade
Total Assets	37,460	35,566	33,266	46,333	31,146	31,332	Upgrade
Accounts Payable	6,305	6,254	4,278	5,793	4,661	3,571	Upgrade
Accrued Expenses	-	1,655	1,482	4,622	2,066	1,533	Upgrade
Current Portion of Long-Term Debt	-	-	-	-	0.24	1.53	Upgrade
Current Portion of Leases	106.1	121.96	120.84	124.53	143.53	148.26	Upgrade
Current Income Taxes Payable	5,391	2,986	2,962	2,962	1,637	1,614	Upgrade
Current Unearned Revenue	-	-	-	-	1,800	-	Upgrade
Other Current Liabilities	6,330	4,233	4,421	3,483	3,238	3,352	Upgrade
Total Current Liabilities	18,132	15,249	13,264	16,984	13,546	10,220	Upgrade
Long-Term Debt	-	-	-	-	-	0.24	Upgrade
Long-Term Leases	41.8	64.69	34.55	76.24	202.5	268.37	Upgrade
Other Long-Term Liabilities	2,559	1,673	1,761	1,848	1,817	1,792	Upgrade
Total Liabilities	20,733	17,790	15,853	19,703	16,364	13,126	Upgrade
Common Stock	1,694	1,694	1,694	1,694	1,694	1,694	Upgrade
Retained Earnings	-	16,351	15,920	25,210	13,345	16,540	Upgrade
Comprehensive Income & Other	15,033	-268.57	-201.58	-274.96	-256.9	-28.22	Upgrade
Shareholders' Equity	16,727	17,776	17,413	26,630	14,783	18,206	Upgrade
Total Liabilities & Equity	37,460	35,566	33,266	46,333	31,146	31,332	Upgrade
Total Debt	147.9	186.65	155.39	200.77	346.27	418.4	Upgrade
Net Cash (Debt)	20,960	18,382	16,386	28,108	11,026	10,200	Upgrade
Net Cash Growth	32.33%	12.18%	-41.70%	154.93%	8.10%	-11.09%	Upgrade
Net Cash Per Share	123.72	108.51	96.73	165.92	65.08	60.21	Upgrade
Filing Date Shares Outstanding	172.12	169.41	169.41	169.41	169.41	169.41	Upgrade
Total Common Shares Outstanding	172.12	169.41	169.41	169.41	169.41	169.41	Upgrade
Working Capital	12,012	12,735	11,679	20,096	8,481	7,529	Upgrade
Book Value Per Share	97.18	104.93	102.79	157.19	87.26	107.47	Upgrade
Tangible Book Value	16,544	17,541	17,072	26,285	14,349	17,710	Upgrade
Tangible Book Value Per Share	96.12	103.54	100.77	155.16	84.70	104.54	Upgrade
Land	-	36.8	36.8	22.49	22.49	560.11	Upgrade
Buildings	-	1,099	1,084	1,041	1,022	4,412	Upgrade
Machinery	-	4,489	4,244	3,937	3,915	8,213	Upgrade
Construction In Progress	-	139.3	203.12	305.02	132.14	1,201	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.